AZENTA INC (AZTA) Stock Price & Overview
NASDAQ:AZTA • US1143401024
Current stock price
The current stock price of AZTA is 25.91 USD. Today AZTA is up by 3.19%. In the past month the price increased by 21.59%. In the past year, price decreased by -3.07%.
AZTA Key Statistics
- Market Cap
- 1.193B
- P/E
- 47.98
- Fwd P/E
- 23.74
- EPS (TTM)
- 0.54
- Dividend Yield
- N/A
AZTA Stock Performance
AZTA Stock Chart
AZTA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AZTA. When comparing the yearly performance of all stocks, AZTA is a bad performer in the overall market: 85.37% of all stocks are doing better.
AZTA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AZTA. No worries on liquidiy or solvency for AZTA as it has an excellent financial health rating, but there are worries on the profitability.
AZTA Earnings
On February 4, 2026 AZTA reported an EPS of 0.09 and a revenue of 148.64M. The company missed EPS expectations (-35.95% surprise) and missed revenue expectations (-0.98% surprise).
AZTA Forecast & Estimates
14 analysts have analysed AZTA and the average price target is 36.28 USD. This implies a price increase of 40.03% is expected in the next year compared to the current price of 25.91.
For the next year, analysts expect an EPS growth of 50.47% and a revenue growth 5.38% for AZTA
AZTA Groups
Sector & Classification
AZTA Financial Highlights
Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 14.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| Debt/Equity | 0 |
AZTA Ownership
AZTA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.34 | 173.435B | ||
| DHR | DANAHER CORP | 19.25 | 126.374B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 133.07 | 43.774B | ||
| A | AGILENT TECHNOLOGIES INC | 17.2 | 32.335B | ||
| WAT | WATERS CORP | 21.31 | 30.551B | ||
| IQV | IQVIA HOLDINGS INC | 12.65 | 26.973B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.31 | 25.603B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 34.06 | 22.323B | ||
| ILMN | ILLUMINA INC | 24.43 | 19.056B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.21 | 11.236B | ||
| RVTY | REVVITY INC | 15.77 | 9.743B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.228B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.24 | 8.276B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AZTA
Company Profile
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Company Info
IPO: 1995-02-02
AZENTA INC
200 Summit Drive, 6Th Floor
Burlington MASSACHUSETTS US
Employees: 3000
Phone: 19782622400
AZENTA INC / AZTA FAQ
Can you describe the business of AZENTA INC?
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
What is the current price of AZTA stock?
The current stock price of AZTA is 25.91 USD. The price increased by 3.19% in the last trading session.
What is the dividend status of AZENTA INC?
AZTA does not pay a dividend.
What is the ChartMill technical and fundamental rating of AZTA stock?
AZTA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for AZTA stock?
14 analysts have analysed AZTA and the average price target is 36.28 USD. This implies a price increase of 40.03% is expected in the next year compared to the current price of 25.91.
Is AZENTA INC (AZTA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AZTA.
Who owns AZENTA INC?
You can find the ownership structure of AZENTA INC (AZTA) on the Ownership tab.